PHASE-II TRIAL OF ORAL METHOTREXATE AND DIPYRIDAMOLE IN COLORECTAL-CARCINOMA

被引：0

作者：

WADLER, S

SUBAR, M

GREEN, MD

WIERNIK, PH

MUGGIA, FM

机构：

[1] MONTEFIORE MED CTR,ALBERT EINSTEIN COLL MED,DEPT ONCOL,BRONX,NY 10467

[2] NYU,RITA & STANLEY H KAPLAN CANC CTR,DEPT INTERNAL MED,DIV MED ONCOL,NEW YORK,NY 10003

来源：

CANCER TREATMENT REPORTS | 1987年 / 71卷 / 09期

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：821 / 824

页数：4

共 16 条

[1] DIPYRIDAMOLE INHIBITS REVERSION BY THYMIDINE OF METHOTREXATE EFFECT AND INCREASES DRUG UPTAKE IN SARCOMA-180 CELLS [J].

CABRAL, S ;

LEIS, S ;

BOVER, L ;

NEMBROT, M ;

MORDOH, J .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES, 1984, 81 (10) :3200-3203

[2]

CAMPBELL MA, 1985, CANCER TREAT REP, V69, P833

[3]

CHAN TCK, 1985, CANCER RES, V45, P3598

[4]

DELMONTE L, 1962, PHARMACOL REV, V14, P91

[5]

FISCHER PH, 1984, CANCER RES, V44, P3355

[6]

HENDERSON ES, 1965, CANCER RES, V25, P1018

[7]

MORDOH J, 1984, P AM ASSOC CANC RES, V25, P321

[8]

MUGGIA FM, 1987, ANTICANCER RES, V7, P161

[9]

NATSUMEDA Y, 1984, CANCER RES, V44, P2475

[10]

NELSON JA, 1984, CANCER RES, V44, P2493

← 1 2 →